Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Findings more pronounced in children with higher mean HbA1c
Read More »Children With Type 1 Diabetes Have Poorer Educational Outcomes
Addition of Sotagliflozin for T1DM Alters Renal Hemodynamics
Addition of SOTA tied to reductions in estimated glomerular filtration rate, blood pressure
Read More »Lifestyle Counseling Frequency, CV Outcomes Linked in Diabetes
More frequent counseling tied to lower incidence of death, CV events in adults with diabetes
Read More »Study Explores Dose Ranges for Efpeglenatide in Early T2DM
Safety profile consistent with other long-acting glucagon-like peptide 1 receptor agonists
Read More »Mediterranean Eating Plan May Help Keep T2DM Patients Off Meds
Med-EatPlan plus extra virgin olive oil linked to lower risk for starting first glucose-lowering medication
Read More »Early Menarche Linked to Risk for T2DM in Rural Chinese Women
Risk for diabetes increased for early menarche group; association partially mediated by adult BMI
Read More »July 2019 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for July 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Oral Semaglutide …
Read More »Childhood BMI, HDL-C Variability May Up Later-Life Diabetes Risk
Greater variability tied to higher risk, independent of mean levels for BMI, HDL cholesterol in childhood
Read More »Oral Semaglutide Reduces HbA1c, Weight in Patients With T2DM
Semaglutide has a safety and tolerability profile consistent with other GLP-1 receptor agonists
Read More »SGLT-2 Inhibitor Use Not Linked to Increased Risk for UTI Events
Findings seen in propensity-matched cohorts versus receipt of DPP-4 inhibitors or GLP-1 agonists
Read More »